DOCSLIB.ORG

— Title to Go Here

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
— Title to Go Here — Cortisol Discussion Can we harmonise clinical decision limits ? Ronda Greaves Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions JCTLM database Certified Reference Material = 6 Reference Measurement Procedure Reference Lab Steroid Pathway Annals of Clin Biochem 2017;54(3):308-322 CAH - 21OHase Deficiency Pharmacokinetics of cortisol replacement drugs Hydrocortisone Well absorbed, Tmax=1 hour Half life 90-100 minutes (1.5 hours) Lasts for 6-8 hours Prednisolone Rapid and well absorbed (Tmax=1-2hrs) Half-life 2-4 hours Lasts for 10-20 hours Dexamethasone Half life 2.8-7.5 hours in 8-16 yr olds, up to 9.5 hours in <2 year olds Lasts for 15-36 hours, 48 hours in < 2 year olds Slide provided by Dr Jeff Kao Micromedex database 2014 New Review Article Annals of Clin Biochem 2017;54(3):308-322 Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions RCPAQAP data – end of 2016 Target set using RMP Instrument Abbreviation n Abbott A 35 Beckman B 13 Ortho O Roche R 47 Siemens S-C 24 Siemens S-I 9 Mass Spec MS 2 2016 Abbott 2016 Beckman 2016 Roche 2016 Siemens - 13 2016 Siemens - 20 2016 Sample Prep / LC-MS/MS Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions Traceability Vitros – “traceable to in-house reference calibrators which have been value assigned to correlate to samples measured by GC-MS” Annals of Clin Biochem 2017;54(3):308-322 Cross-reactivity with cortisol v1 COBAS Electrochemiluminescence Immunoassay (ECLIA) For the antibody derivate used, the following cross- reactivities (%) were found: substance added per 10 μg/mL: cortisol-21-sulfate 0.04 cortisone 0.30 dexamethasone 0.08 prednisone 0.28 substance added per 0.1 μg/mL: prednisolone 171 6-α-methylprednisolone 389 E.g. If a patient is taking prednisolone, then for every 0.1 mcg/mL of prednisolone, there is 171% cross-reactivity i.e. 0.17 ug/mL of the “cortisol” level is prednisolone Change to cortisol methods 20 RMIT University©2015 Changes to standardisation approach Cortisol I Cortisol II 21 RMIT 2015 Vietnam CPC University©2015 Cross Reactivity Table Instrument A B O R S-C S-I MS 11 beta hydroxyprogesterone 0.2 2.52 1 11 beta OH A 0 11 beta OH E 0 11 keto A 0 11 keto E 1.8 11-deoxycorticosterone 0 0.91 0.035 0.227 1.8 0 11-deoxycortisol 1.9 17.8 0.95 3.62 23.3 0 17 alpha OHP 0.6 5.33 0.553 0 1.2 0 Instrument A B O 17 OH pregnanoloneR 0.1S-C S-I 0 MS 20 alpha dihydrocortisol 0.5 20 alpha dihydrocortisone 0.2 11-deoxycorticosterone 0 0.91 0.03520 beta dihydrocortisol 0.227 1.8 1.3 0 20 beta dihydrocortisone 0 11-deoxycortisol 1.9 17.8 0.9521 deoxycortisol 3.62 23.3 0.515 8.1 0 0 6 beta OH cortisol 0.2 6.8 6-alpha-methylprednisolone 0.1 5.94 14.7 26.2 17 alpha OHP 0.6 5.33 0.553Aldosterone 0 0 1.2 0.3 0 0 allo-THF 6.5 17 OH pregnanolone 0.1 Alpha cortol 0 0 Alpha cortolone 0 Androstenedione 0 0 21 deoxycortisol Beclomethasone 0.515 0 8.1 0 Beta cortol 0 0.006 0 6 beta OH cortisol 0.2 Beta cortolone 0 6.80 0 beta sitosterol 0 Betamethasone 0 6-alpha-methylprednisolone 0.1 5.94Budesonide 14.7 0 26.2 Canrenone 0.3 Cortisone 2.7 8.06 0.13Canrenone 4.68 0 31.1 0 Corticosterone 0.9 2.08 1.03 1.29 5.3 8.6 cortisol 21 glucuronide 0.2 Dexamethasone 0 0.04 0.244Cortisone 02.7 8.06 0.20.13 4.68 31.1 0 0 Dehydrocorticosterone 1.9 Dexamethasone 0 0.04 0.244 0 0.2 0 Fludrocortisone 36.6 3.85DHEA 0 0 0.2 DHEAS 0 0 Prednisolone 12.3 23.92 26.8estradiol 7.32 0 109 49 Estriol 0 0.006 0 Estrone 0 0 Prednisone 0.6 3.05 0.076Fludrocortisone 2.3336.6 3.8534 0 5.90.2 Fluticasone 0 0 Medroxyprogesterone 0 Methotrexate 0 Methylprednisolone 21 Mornetasone 0 Prednisolone 12.3 23.92 26.8 7.32 109 49 Prednisone 0.6 3.05 0.076 2.33 34 5.9 Pregnanediol 0 0 Pregnanetriol 0 0 Pregnenolone 0 0.5 Progesterone 0 0.46 0.459 0 0 0 Spirolactone 0 0 0 Testosterone 0 0.007 0.2 tetracycline 0 THE 0.1 0.3 0 THF 0.5 0.159 0 0.9 THS 0 Topiramate 0 Triamicinolone 0.5 0.022 Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions 8am RI from package inserts 700 600 500 400 lower RI nmol/L Upper RI 300 200 100 0 Abbott Beckman Ortho Roche Siemens - C Siemens - I Mass Spec 8am cortisol RI Package Insert RCPAQAP RI survey n Low High A 0 B 1 140 640 O 1 172 497 R 14 142 539 S-C 3 220 660 S-I 1 100 540 RCPAQAP RI survey 2016 All labs Roche 800 700 700 600 600 500 500 400 Lower Low nmol/L nmol/L 400 Upper High 300 300 200 200 100 100 0 0 Published Adult LC-MS/MS RI LC-MS/MS Published RI Male Female What does Graham say ? http://www.sydpath.stvincents.com.au/spec_db/ 29 RMIT University© Clinical Biochemistry 1 Post Synacthen lower RI Annals of Clin Biochem 2017;54(3):308-322 Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions Questions What are the areas we can agree on ? • Age • Gender • Instrument specific RI • Critical low level Can we improve the traceability information in our kit inserts ?.
Load more

Recommended publications
  • United States July 2016 2 Table of Contents
    Deuterium Labelled Compounds United States July 2016 2 Table of Contents International Distributors 3 Corporate Overview 4 General Information 5 Pricing and Payment 5 Quotations 5 Custom Synthesis 5 Shipping 5 Quality Control 6 Quotations 6 Custom Synthesis 6 Shipping 6 Quality Control 6 Chemical Abstract Service Numbers 6 Handling Hazardous Compounds 6 Our Products are Not Intended for Use in Humans 7 Limited Warranty 7 Packaging Information 7 Alphabetical Listings 8 Stock Clearance 236 Products by Category 242 n-Alkanes 243 α-Amino Acids, N-Acyl α-Amino Acids, N-t-BOC Protected α-Amino Acid 243 and N-FMOC Protected α-Amino Acids Buffers and Reagents for NMR Studies 245 Detergents 245 Environmental Standards 246 Fatty Acids and Fatty Acid Esters 249 Flavours and Fragrances 250 Gases 253 Medical Research Products 254 Nucleic Acid Bases and Nucleosides 255 Pesticides and Pesticide Metabolites 256 Pharmaceutical Standards 257 Polyaromatic Hydrocarbons (PAHs), Alkyl-PAHs, Amino-PAHs, 260 Hydroxy-PAHs and Nitro-PAHs Polychlorinated Biphenyls (PCBs) 260 Spin Labels 261 Steroids 261 3 International Distributors C Beijng Zhenxiang H EQ Laboratories GmbH Australia K Technology Company Graf-von-Seyssel-Str. 10 Rm. 15A01, Changyin Bld. 86199 Augsburg Austria H No. 88, YongDingLu Rd. Germany Beijing 100039 Tel.: (49) 821 71058246 Belgium J China Fax: (49) 821 71058247 Tel.: (86) 10-58896805 [email protected] China C Fax: (86) 10-58896158 www.eqlabs.de Czech Republic H [email protected] Germany, Austria, China Czech Republic, Greece, Denmark I Hungary,
    [Show full text]
  • A New Robust Technique for Testing of Glucocorticosteroids in Dogs and Horses Terry E
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2007 A new robust technique for testing of glucocorticosteroids in dogs and horses Terry E. Webster Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Veterinary Toxicology and Pharmacology Commons Recommended Citation Webster, Terry E., "A new robust technique for testing of glucocorticosteroids in dogs and horses" (2007). Retrospective Theses and Dissertations. 15029. https://lib.dr.iastate.edu/rtd/15029 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. A new robust technique for testing of glucocorticosteroids in dogs and horses by Terry E. Webster A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Toxicology Program o f Study Committee: Walter G. Hyde, Major Professor Steve Ensley Thomas Isenhart Iowa State University Ames, Iowa 2007 Copyright © Terry Edward Webster, 2007. All rights reserved UMI Number: 1446027 Copyright 2007 by Webster, Terry E. All rights reserved. UMI Microform 1446027 Copyright 2007 by ProQuest Information and Learning Company. All rights reserved. This microform edition is protected against unauthorized copying under Title 17, United States Code. ProQuest Information and Learning Company 300 North Zeeb Road P.O. Box 1346 Ann Arbor, MI 48106-1346 ii DEDICATION I want to dedicate this project to my wife, Jackie, and my children, Shauna, Luke and Jake for their patience and understanding without which this project would not have been possible.
    [Show full text]
  • A Thesis Entitled "APPLICATIONS of GAS CHROMATOGRAPHY
    A Thesis entitled "APPLICATIONS OF GAS CHROMATOGRAPHY - MASS SPECTROMETRY IN STEROID CHEMISTRY" Submitted in part fulfilment of the requirements for admittance to the degree of Doctor of Philosophy in The University of Glasgow by T.A. Baillie, B.Sc. University of Glasgow 1973. ProQuest Number: 11017930 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 11017930 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENTS I would like to express my sincere thanks to Dr. C.3.W. Brooks for his guidance and encouragement at all times, and to Professors R.A. Raphael, F.R.S., and G.W. Kirby, for the opportunity to carry out this research. Thanks are also due to my many colleagues for useful discussions, and in particular to Dr. B.S. Middleditch who was associated with me in the work described in Section 3 of this thesis. The work was carried out during the tenure of an S.R.C. Research Studentship, which is gratefully acknowledged. Finally, I would like to thank Miss 3.H.
    [Show full text]
  • Steroid Metabolites Support Evidence of Autism As a Spectrum
    behavioral sciences Article Steroid Metabolites Support Evidence of Autism as a Spectrum Benedikt Andreas Gasser 1,*, Johann Kurz 2, Bernhard Dick 1,3 and Markus Georg Mohaupt 1,4 1 Department of Clinical Research, University of Bern, 3010 Berne, Switzerland; [email protected] (B.D.); [email protected] (M.G.M.) 2 Intersci Research Association, Karl Morre Gasse 10, 8430 Leibnitz, Austria; [email protected] 3 Division of Nephrology/Hypertension, University of Bern, 3010 Berne, Switzerland 4 Teaching Hospital Internal Medicine, Lindenhofgruppe, 3006 Berne, Switzerland * Correspondence: [email protected] Received: 30 March 2019; Accepted: 6 May 2019; Published: 9 May 2019 Abstract: Objectives: It is common nowadays to refer to autism as a spectrum. Increased evidence of the involvement of steroid metabolites has been shown by the presence of stronger alterations in Kanner’s syndrome compared with Asperger syndrome. Methods: 24 h urine samples were collected from 20 boys with Asperger syndrome, 21 boys with Kanner’s syndrome, and identically sized control groups, each matched for age, weight, and height for comprehensive steroid hormone metabolite analysis via gas chromatography–mass spectrometry. Results: Higher levels of most steroid metabolites were detected in boys with Kanner’s syndrome and Asperger syndrome compared to their matched controls. These differences were more pronounced in affected individuals with Kanner’s syndrome versus Asperger syndrome. Furthermore, a specific and unique pattern of alteration of androsterone, etiocholanolone, progesterone, tetrahydrocortisone, and tetrahydrocortisol was identified in boys with Kanner’s syndrome and Asperger syndrome. Interestingly, in both matched samples, only androsterone, etiocholanolone, progesterone, tetrahydrocortisone, tetrahydrocortisol, and 5a-tetrahydrocortisol groups were positively correlated.
    [Show full text]
  • Mass Spec Testing for Steroid Hormone Profiles: Making an Impact on Patient Care
    Mass Spec Testing for Steroid Hormone Profiles: Making an Impact on Patient Care R.J. Singh, Ph.D. Mayo Clinic Objectives •Congenital Adrenal Hyperplasia (CAH) •Sex Steroids •Cushing’s CAH New Born Screening 1 CAH CholesterolBiosynthesis of Steroids Pregnenolone 17- OH Pregnenolone DHEA ase ’ -----------------------------------------------------------------------------3SDH 17,20 desmolase 17 OH Progesterone 17-OH Progesterone Androstenedione 21 OH'ase 17b SDH ---------------------------------------------- Aromatase 21-Deoxycorti- 11-deoxycortisol Testosterone costerone 11 OH'ase Aromatase ---------------------------------------------- Estrone Corticosterone Cortisol Estradiol 17b SDH 18 OH'ase ---------------------- Cortisone --- Aldosterone STEROID PROFILE BY LC MS/MS TIC: from 051200-36 9.5e5 8 9.0e5 1. Cortisone 8.5e5 2. Cortisol, Cortisol d-4 8.0e5 3. 21-Deoxycortisol 4. Corticosterone 7.5e5 5. 11-Deoxycortisol 7.0e5 6. Androstendione 6.5e5 7. DOC 8. 17-Hydroxyprogesterone 6.0e5 17-Hydroxypregnenolone 5.5e5 9. Progesterone 5.0e5 10. Pregnenolone Intensity, cps 4.5e5 4.0e5 3.5e5 3.0e5 6 2.5e5 5 7 10 2.0e5 1.5e5 34 2 1.0e5 1 5.0e4 9 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 Time, min 6 2 Basics of MS Method Basics of MS Method Lack of Standardization 3 RIA vs. LC-MS/MS 14000 12000 10000 8000 6000 4000 Mayo LC/MS/MS ng/dL LC/MS/MS Mayo 2000 0 0 2000 4000 6000 8000 10000 12000 14000 Ext/RIA ng/dL Correlation Between Two Sites 4 Bland Altman Plot (N=76) 1000 + 2 SD = 801.4 500 + 1 SD = 405.8 Mean difference= 10.1 0 (ng/dL) - 1 SD = 385.6 -500
    [Show full text]
  • A-1-Antitrypsin Deficiency: Phenotype Vs. Genotype
    Impact of Tandem Mass Spectrometry in Clinical Diagnostics R.J. Singh, Ph.D. Mayo Clinic Definition Diagnosis or Di`ag`nos´tics • Identification of a disease, disorder, or syndrome through a method of consistent and accurate analysis. Laboratory Automation Picture of the UVA lab here Methodologies for Analysis RIA GC-FID CLIA LC-UV/EC ELISA GC-MS FIA LC-MS ICMA LC-MS/MS Biosynthesis of Steroids Cholesterol Pregnenolone 17- OH Pregnenolone DHEA ---------------------3βSDH -------------------------------------------------------- 17,20 desmolase 17 OH’ase Progesterone 17-OH Progesterone Androstenedione 21 OH'ase 17b SDH ---------------------------------------------- Aromatase ------ 11-Deoxycorticosterone 11-deoxycortisol Testosterone 11 OH'ase Aromatase ---------------------------------------------- ------ Estrone Corticosterone Cortisol Estradiol 17b SDH 18 OH'ase ---------------------- Cortisone --- Aldosterone Cushing’s Syndrome Introduction Hypothalamus CRH Pituitary Cortisol ACTH - + Adrenal Gland Cortisol ACTH-Dependent Cushing’s Syndrome Cushing’s Disease Ectopic ACTH Syndrome ACTH-Independent Cushing’s Syndrome Adrenal adenoma Adrenal carcinoma Adrenal Gland Adrenaline Adrenal Cortex (outer) Adrenal Medulla (center) http://www.pathology.vcu.edu/education/endocrine/endocrine/adrenal/micro/adrad1x.gif Obesity Trends* Among U.S. Adults BRFSS, 1990, 1998, 2006 (*BMI ≥30, or about 30 lbs. overweight for 5’4” person) 1990 1998 2006 No Data <10% 10%–14% 15%–19% 20%–24% 25%–29% ≥30% Biosynthesis of Steroids Cholesterol Pregnenolone 17- OH
    [Show full text]
  • United States Patent (19) 11 Patent Number: 6,068,830 Diamandis Et Al
    US00606883OA United States Patent (19) 11 Patent Number: 6,068,830 Diamandis et al. (45) Date of Patent: May 30, 2000 54) LOCALIZATION AND THERAPY OF FOREIGN PATENT DOCUMENTS NON-PROSTATIC ENDOCRINE CANCER 0217577 4/1987 European Pat. Off.. WITH AGENTS DIRECTED AGAINST 0453082 10/1991 European Pat. Off.. PROSTATE SPECIFIC ANTIGEN WO 92/O1936 2/1992 European Pat. Off.. WO 93/O1831 2/1993 European Pat. Off.. 75 Inventors: Eleftherios P. Diamandis, Toronto; Russell Redshaw, Nepean, both of OTHER PUBLICATIONS Canada Clinical BioChemistry vol. 27, No. 2, (Yu, He et al), pp. 73 Assignee: Nordion International Inc., Canada 75-79, dated Apr. 27, 1994. Database Biosis BioSciences Information Service, AN 21 Appl. No.: 08/569,206 94:393008 & Journal of Clinical Laboratory Analysis, vol. 8, No. 4, (Yu, He et al), pp. 251-253, dated 1994. 22 PCT Filed: Jul. 14, 1994 Bas. Appl. Histochem, Vol. 33, No. 1, (Papotti, M. et al), 86 PCT No.: PCT/CA94/00392 Pavia pp. 25–29 dated 1989. S371 Date: Apr. 11, 1996 Primary Examiner Yvonne Eyler S 102(e) Date: Apr. 11, 1996 Attorney, Agent, or Firm-Banner & Witcoff, Ltd. 87 PCT Pub. No.: WO95/02424 57 ABSTRACT It was discovered that prostate-specific antigen is produced PCT Pub. Date:Jan. 26, 1995 by non-proStatic endocrine cancers. It was further discov 30 Foreign Application Priority Data ered that non-prostatic endocrine cancers with Steroid recep tors can be stimulated with Steroids to cause them to produce Jul. 14, 1993 GB United Kingdom ................... 93.14623 PSA either initially or at increased levels.
    [Show full text]
  • Human Steroid Biosynthesis, Metabolism and Excretion Are
    Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes Schiffer, Lina; Barnard, Lise; Baranowski, Elizabeth; Gilligan, Lorna; Taylor, Angela; Arlt, Wiebke; Shackleton, Cedric; Storbeck, Karl-Heinz License: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Document Version Peer reviewed version Citation for published version (Harvard): Schiffer, L, Barnard, L, Baranowski, E, Gilligan, L, Taylor, A, Arlt, W, Shackleton, C & Storbeck, K-H 2019, 'Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review', The Journal of Steroid Biochemistry and Molecular Biology. Link to publication on Research at Birmingham portal Publisher Rights Statement: This is the accepted manuscript for a forthcoming publication in Journal of Steroid Biochemistry and Molecular Biology. General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • Adrenocortical Steroid Metabolism and Adrenal Cortical Function in Liver Disease
    ADRENOCORTICAL STEROID METABOLISM AND ADRENAL CORTICAL FUNCTION IN LIVER DISEASE Ralph E. Peterson J Clin Invest. 1960;39(2):320-331. https://doi.org/10.1172/JCI104043. Research Article Find the latest version: https://jci.me/104043/pdf ADRENOCORTICAL STEROID METABOLISM AND ADRENAL CORTICAL FUNCTION IN LIVER DISEASE BY RALPH E. PETERSON * (From The National Institute of Arthritis and MVetabolic Diseases, Bethesda, Md.) (Submitted for publication July 27, 1959; accepted October 1, 1959) Zondek (1) as early as 1934 demonstrated that to man disappear rapidly from the blood (15, 16). enzymes of the liver destroyed the biological ac- Only minimal quantities are lost via the expired tivity of the estrogens. Since then both in tivo CO2 (17) or the biliary or gastrointestinal tract and in vitro studies have provided much evidence (15, 16). Also, practically all of the administered to show that the liver is the organ primarily re- steroid is metabolized prior to its excretion in the sponsible for the catabolism of the steroid hor- urine (15, 16), and thus it is apparent that urinary mones: estrogens, androgens, progesterone, and excretion plays a relatively minor part in elimi- the corticosteroids (2). However, not until the nating the biologically active steroid. Thus, meta- development of improved methods for measure- bolic transformation by the liver must play the pre- ment of certain of the adrenocortical steroids and dominant role in terminating the action of the their metabolites, and the availability of labeled steroids. radioactive cortisol, corticosterone, and aldosterone Because of the major role of the liver in the has it been possible accurately to evaluate the in- catabolism of the corticosteroids, it might be ex- fluence of liver disease on the rate of degradation pected that this organ could indirectly influence and synthesis of the steroids in man.
    [Show full text]
  • Transcortin: a Corticosteroid-Binding Protein of Plasma
    TRANSCORTIN: A CORTICOSTEROID-BINDING PROTEIN OF PLASMA. III. THE EFFECTS OF VARIOUS STEROIDS Avery A. Sandberg, … , W. Roy Slaunwhite Jr., Anne C. Carter J Clin Invest. 1960;39(12):1914-1926. https://doi.org/10.1172/JCI104216. Research Article Find the latest version: https://jci.me/104216/pdf TRANSCORTIN: A CORTICOSTEROID-BINDING PROTEIN OF PLASMA. III. THE EFFECTS OF VARIOUS STEROIDS * t By AVERY A. SANDBERG, W. ROY SLAUNWHITE, JR. AND ANNE C. CARTER (From the Roswell Park Memiiorial Intstituite, Buffalo, N. Y'. and the Departmetnitt of Medicinie, State University of New York, College of Medicine at New York City, N. Y.) (Submitted for publication June 21, 1960; accepted August 11, 1960) In previous publications (1, 2) we have de- jects under variotus condlitions and the effects of scribed some of the characteristics of transcortin, a admiiniistered steroi(ls on these levels. plasma protein (or proteins) with high affinity for cortisol and corticosterone. In addition, we have MI ETHODS AND MATERIALS shown that plasmiia transcortin levels are elevated The binding of C'4-cortisol by plasma transcortin and during pregnancy and following administration of the transcortiin capacity were determined by methods estrogens (1-3). A different interpretation of the previously described (1, 2). The terms "transcortin bind- findings in these two states has been given by ing of C'4-cortisol" and "transcortin capacity" have been defiine(d in a previous publication (2). At this point it Daughaday and AMariz (4, 5). Transcortin levels may be appropriate to reiterate some important aspects were substantially lower in the plasma of newborn of the methodologies and terms used.
    [Show full text]
  • Human Steroid Biosynthesis, Metabolism and Excretion Are
    University of Birmingham Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes Schiffer, Lina; Barnard, Lise; Baranowski, Elizabeth; Gilligan, Lorna; Taylor, Angela; Arlt, Wiebke; Shackleton, Cedric; Storbeck, Karl-Heinz DOI: 10.1016/j.jsbmb.2019.105439 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Schiffer, L, Barnard, L, Baranowski, E, Gilligan, L, Taylor, A, Arlt, W, Shackleton, C & Storbeck, K-H 2019, 'Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review', The Journal of Steroid Biochemistry and Molecular Biology, vol. 194, 105439. https://doi.org/10.1016/j.jsbmb.2019.105439 Link to publication on Research at Birmingham portal Publisher Rights Statement: Schiffer, L, Barnard, L, Baranowski, E, Gilligan, L, Taylor, A, Arlt, W, Shackleton, C & Storbeck, K-H. (2019) 'Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review', The Journal of Steroid Biochemistry and Molecular Biology, vol. 194, 105439, pp. 1-25. https://doi.org/10.1016/j.jsbmb.2019.105439 General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research.
    [Show full text]
  • Based Quantification of Hydrolyzed Urinary Steroids
    Published OnlineFirst January 19, 2010; DOI: 10.1158/1055-9965.EPI-09-0581 Cancer Research Article Epidemiology, Biomarkers & Prevention Systematic Error in Gas Chromatography-Mass Spectrometry– Based Quantification of Hydrolyzed Urinary Steroids Ju-Yeon Moon1,2, Young Wan Ha1, Myeong Hee Moon2, Bong Chul Chung1, and Man Ho Choi1 Abstract Gas chromatography-mass spectrometry–based metabolite profiling can lead to an understanding of vari- ous disease mechanisms as well as to identifying new diagnostic biomarkers by comparing the metabolites related in quantification. However, the unexpected transformation of urinary steroids during enzymatic hy- drolysis with Helix pomatia could result in an underestimation or overestimation of their concentrations. A comparison of β-glucurondase extracted from Escherichia coli revealed 18 conversions of 84 steroids tested as an unexpected transformation under hydrolysis with β-glucuronidase/arylsulfatase extracted from Helix pomatia. In addition to the conversion of 3β-hydroxy-5-ene steroids into 3-oxo-4-ene steroids, which has been reported, the transformation of 3β-hydroxy-5α–reduced and 3β-hydroxy-5β–reduced steroids to 3-oxo- 5α–reduced and 3-oxo-5β–reduced steroids, respectively, was newly observed. The formation of by-products was in proportion to the concentration of substrates becoming saturated against the enzyme. The substances belonging to these three steroid groups were undetectable at low concentrations, whereas the corresponding by-products were overestimated. These results indicate that the systematic error in the quantification of uri- nary steroids hydrolyzed with Helix pomatia can lead to a misreading of the clinical implications. All these hydrolysis procedures are suitable for study purposes, and the information can help prevent false evaluations of urinary steroids in clinical studies.
    [Show full text]